Skip to main content

Cancer Genetics

  • ISSN: 2210-7762

Editor-In-Chief: Kulkarni

Next planned ship date: June 6, 2024

  • 5 Year impact factor: 2
  • Impact factor: 1.9

The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical dia… Read more

Subscription options

Next planned ship date:
June 6, 2024

Institutional subscription on ScienceDirect

Request a sales quote
The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center


Cancer Genetics is proud to be affiliated with the Cancer Genomics Consortium.